Sentinel lymph node biopsy in patients with breast cancer using superparamagnetic iron oxide and a magnetometer

Breast Cancer

Volumn 20, Issue 3, 2013, Pages 223-229

  Shiozawa, Mikio ^a,b   Lefor, Alan T ^b   Hozumi, Yasuo ^b   Kurihara, Katsumi ^a   Sata, Naohiro ^b   Yasuda, Yoshikazu ^b   Kusakabe, Moriaki ^c  

^a Oyama Municipal Hospital   (Japan)

^b JICHI MEDICAL UNIVERSITY   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

Breast cancer; Radioisotopes; Sentinel lymph node biopsy; Superparamagnetic iron

Indexed keywords

BLUE DYE; DYE; FERUCARBOTRAN; SUPERPARAMAGNETIC IRON OXIDE; TRACER; UNCLASSIFIED DRUG; COLORING AGENT; DISULFINE BLUE; FERRIC ION; FERRIC OXIDE; FUCHSINE; MAGNETITE NANOPARTICLE;

ADULT; AGED; ANALYTICAL EQUIPMENT; ARTICLE; AXILLARY LYMPH NODE; BREAST AREOLA; BREAST CANCER; CLINICAL ARTICLE; FALSE NEGATIVE RESULT; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IRON TRANSPORT; LYMPH NODE DISSECTION; LYMPH VESSEL; MAGNETIC FIELD; MAGNETOMETER; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SENTINEL LYMPH NODE BIOPSY; BREAST NEOPLASMS; CANCER STAGING; CELL TRACKING; DIAGNOSTIC USE; FOLLOW UP; LYMPH NODE; MAGNETOMETRY; MIDDLE AGED; PATHOLOGY; PROCEDURES; PROGNOSIS;

ADULT; AGED; BREAST NEOPLASMS; CELL TRACKING; COLORING AGENTS; FEMALE; FERRIC COMPOUNDS; FOLLOW-UP STUDIES; HUMANS; LYMPH NODES; MAGNETITE NANOPARTICLES; MAGNETOMETRY; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; ROSANILINE DYES; SENTINEL LYMPH NODE BIOPSY;

EID: 84880046712     PISSN: 13406868     EISSN: 18804233     Source Type: Journal    
DOI: 10.1007/s12282-011-0327-9     Document Type: Article

References (21)

1. Krag DN, Weaver DL, Alex JC, Fairbank JT. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol. 1993;2:335-9. (Pubitemid 24019852)
2. Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg. 1994;220:391-8.
3. Cody HS. Sentinel lymph node mapping in breast cancer. Breast Cancer. 1999;6:13-22.
4. Albertini JJ, Lyman GH, Cox C, Yeatman T, Balducci L, Ku N, et al. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA. 1996;276:1818-22. (Pubitemid 26406231)
5. Derossis AM, Fey J, Yeung H, Yeh SD, Heerdt AS, Petrek J, et al. A trend analysis of the relative value of blue dye and isotope localization in 2,000 consecutive cases of sentinel node biopsy for breast cancer. J Am Coll Surg. 2001;193:473-8. (Pubitemid 33043448)
6. Radovanovic Z, Golubovic A, Plzak A, Stojiljkovic B, Radovanovic D. Blue dye versus combined blue dye-radioactive tracer technique in detection of sentinel lymph node in breast cancer. Eur J Surg Oncol. 2004;30:913-7. (Pubitemid 39462518)
7. Motomura K, Inaji H, Komoike Y, Hasegawa Y, Kasugai T, Noguchi S, et al. Combination technique is superior to dye alone in identification of the sentinel node in breast cancer patients. J Surg Oncol. 2001;76:95-9.
8. Krag DN, Anderson SJ, Julian TB, Brown AM, Harlow SP, Ashikaga T, et al. Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomized phase III trial. Lancet Oncol. 2007;8:881-8. (Pubitemid 47488052)
9. Dale PS, Williams JT IV. Axillary staging utilizing selective sentinel lymphadenectomy for patients with invasive breast carcinoma. Am Surg. 1998;64:28-31.
10. Guenther JM, Krishnamoorthy M, Tan LR. Sentinel lymphadenectomy for breast cancer in a community managed care setting. Cancer J Sci Am. 1997;3:336-40.
11. Grube BJ, Giuliano AE. Observation of the breast cancer patient with a tumor-positive sentinel node: implications of the ACOSOG Z0011 trial. Semin Surg Oncol. 2001;20:230-7. (Pubitemid 32830834)
12. Miner TJ, Shriver CD, Flicek PR, Miner FC, Jaques DP, Maniscalco-Theberge ME, et al. Guidelines for the safe use of radioactive materials during localization and resection of the sentinel lymph node. Ann Surg Oncol. 1999;6:75-82. (Pubitemid 29077491)
13. Omoto K, Hozumi Y, Omoto Y, Taniguchi N, Itoh K, Fujii Y, et al. Sentinel node detection in breast cancer using contrast-enhanced sonography with 25% albumin - initial clinical experience. J Clin Ultrasound. 2006;34:317-26. (Pubitemid 44300058)
14. Kitai T, Inomoto T, Miwa M, Shikayama T. Fluorescence navigation with indocyanine green for detecting sentinel lymph nodes in breast cancer. Breast Cancer. 2005;12:211-5.
15. Weissleder R, Elizondo G, Wittenberg J, Lee AS, Josephson L, Brady TJ. Ultrasmall superparamagnetic iron oxide: an intravenous contrast agent for assessing lymph nodes with MR imaging. Radiology. 1990;175:494-8. (Pubitemid 20135291)
16. Weissleder R, Elizondo G, Wittenberg J, Rabito CA, Bengele HH, Josephson L. Ultrasmall superparamagnetic iron oxide: characterization of a new class of contrast agents for MR imaging. Radiology. 1990;175:489-93. (Pubitemid 20135290)
17. Michel SC, Keller TM, Frohlich JM, Fink D, Caduff R, Seifert B, et al. Preoperative breast cancer staging: MR imaging of the axilla with ultrasmall superparamagnetic iron oxide enhancement. Radiology. 2002;225:527-36. (Pubitemid 35239258)
18. Ferrucci JT, Stark DD. Iron oxide-enhanced MR imaging of the liver and spleen: review of the first 5 years. AJR Am J Roentgenol. 1990;155:943-50. (Pubitemid 20356987)
19. Nakagawa T, Minamiya Y, Katayose Y, Saito H, Taguchi K, Imano H, et al. A novel method for sentinel lymph node mapping using magnetite in patients with non-small cell lung cancer. J Thorac Cardiovasc Surg. 2003;126:563-7. (Pubitemid 37048527)
20. Minamiya Y, Ito M, Katayose Y, Saito H, Imai K, Sato Y, et al. Intraoperative sentinel lymph node mapping using a new sterilizable magnetometer in patients with nonsmall cell lung cancer. Ann Thorac Surg. 2006;81:327-30. (Pubitemid 41815429)
21. Ishiyama K, Sashi R, Katayose Y, Tomura N, Watarai J, Narita K. Sentinel lymph node after intramammary injection of superparamagnetic iron oxide (article in Japanese). Nippon Igaku Hoshasen Gakkai Zasshi. 2002;62:744-6.